Federated Hermes’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.7M | Sell |
27,775
-1,487
| -5% | -$686K | 0.02% | 574 |
|
|
2026
Q1 | $14.1M | Buy |
29,262
+17,235
| +143% | +$8.82M | 0.02% | 554 |
|
|
2025
Q4 | $6.75M | Buy |
12,027
+24
| +0.2% | +$13.6K | 0.01% | 726 |
|
|
2025
Q3 | $6.17M | Sell |
12,003
-19,947
| -62% | -$8.71M | 0.01% | 699 |
|
|
2025
Q2 | $10M | Buy |
31,950
+9,893
| +45% | +$2.97M | 0.02% | 575 |
|
|
2025
Q1 | $6.72M | Buy |
22,057
+1,543
| +8% | +$519K | 0.01% | 644 |
|
|
2024
Q4 | $6.82M | Sell |
20,514
-316
| -2% | -$107K | 0.01% | 637 |
|
|
2024
Q3 | $6.95M | Buy |
20,830
+1,094
| +6% | +$416K | 0.02% | 653 |
|
|
2024
Q2 | $8.13M | Buy |
19,736
+771
| +4% | +$305K | 0.02% | 597 |
|
|
2024
Q1 | $7.66M | Buy |
18,965
+1,151
| +6% | +$405K | 0.02% | 625 |
|
|
2023
Q4 | $5.46M | Sell |
17,814
-11,261
| -39% | -$3.04M | 0.01% | 695 |
|
|
2023
Q3 | $7.04M | Buy |
29,075
+18,088
| +165% | +$4.63M | 0.02% | 619 |
|
|
2023
Q2 | $2.64M | Sell |
10,987
-407
| -4% | -$84.5K | 0.01% | 871 |
|
|
2023
Q1 | $2.14M | Buy |
11,394
+7,114
| +166% | +$1.47M | 0.01% | 937 |
|
|
2022
Q4 | $909K | Sell |
4,280
-375
| -8% | -$74.9K | ﹤0.01% | 1166 |
|
|
2022
Q3 | $732K | Sell |
4,655
-505
| -10% | -$80.6K | ﹤0.01% | 1221 |
|
|
2022
Q2 | $772K | Sell |
5,160
-1,575
| -23% | -$228K | ﹤0.01% | 1240 |
|
|
2022
Q1 | $1.1M | Sell |
6,735
-2,719
| -29% | -$448K | ﹤0.01% | 1209 |
|
|
2021
Q4 | $2.06M | Buy |
9,454
+1,934
| +26% | +$405K | ﹤0.01% | 1052 |
|
|
2021
Q3 | $1.42M | Sell |
7,520
-19,318
| -72% | -$3.52M | ﹤0.01% | 1152 |
|
|
2021
Q2 | $4.74M | Sell |
26,838
-29,388
| -52% | -$5.07M | 0.01% | 850 |
|
|
2021
Q1 | $9.22M | Buy |
56,226
+48,487
| +627% | +$7.42M | 0.02% | 688 |
|
|
2020
Q4 | $1.08M | Sell |
7,739
-134,354
| -95% | -$16.9M | ﹤0.01% | 1295 |
|
|
2020
Q3 | $15.9M | Sell |
142,093
-71,629
| -34% | -$8.28M | 0.04% | 465 |
|
|
2020
Q2 | $19.9M | Sell |
213,722
-74,992
| -26% | -$6.38M | 0.05% | 395 |
|
|
2020
Q1 | $21.2M | Sell |
288,714
-225,477
| -44% | -$19.6M | 0.06% | 323 |
|
|
2019
Q4 | $43.2M | Buy |
514,191
+283,854
| +123% | +$22M | 0.1% | 244 |
|
|
2019
Q3 | $19.4M | Buy |
230,337
+139,562
| +154% | +$10.5M | 0.05% | 375 |
|
|
2019
Q2 | $5.94M | Buy |
90,775
+8,007
| +10% | +$461K | 0.01% | 733 |
|
|
2019
Q1 | $4.88M | Sell |
82,768
-158,496
| -66% | -$9.47M | 0.01% | 791 |
|
|
2018
Q4 | $12.8M | Buy |
241,264
+96,039
| +66% | +$5.27M | 0.03% | 418 |
|
|
2018
Q3 | $8.7M | Buy |
145,225
+14,105
| +11% | +$772K | 0.02% | 621 |
|
|
2018
Q2 | $5.64M | Sell |
131,120
-41,693
| -24% | -$1.68M | 0.02% | 647 |
|
|
2018
Q1 | $6.03M | Sell |
172,813
-19,782
| -10% | -$723K | 0.02% | 572 |
|
|
2017
Q4 | $6.98M | Buy |
192,595
+336
| +0.2% | +$11.8K | 0.02% | 515 |
|
|
2017
Q3 | $6.13M | Buy |
192,259
+7,790
| +4% | +$238K | 0.02% | 504 |
|
|
2017
Q2 | $5.35M | Buy |
184,469
+5,554
| +3% | +$156K | 0.02% | 556 |
|
|
2017
Q1 | $5.34M | Buy |
+178,915
| New | +$5.77M | 0.02% | 564 |
|
|
2016
Q4 | – | Sell |
-75,000
| Closed | -$2.24M | – | 2148 |
|
|
2016
Q3 | $2.24M | Buy |
+75,000
| New | +$2.19M | 0.01% | 808 |
|
Other funds holding MEDP
WA
Federated Hermes's MEDP Position: Q2 2026 in Review
Federated Hermes reduced its Medpace (MEDP) stake by 5.1% in Q2 2026, selling an estimated $686K and leaving 27,775 shares worth $14.7M. The position accounts for 0.02% of the portfolio, ranked #574.
Federated Hermes first reported a position in MEDP in Q3 2016 and has held it in 39 quarters since. The position peaked at $43.2M in Q4 2019. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Federated Hermes held 27,775 shares of Medpace worth $14.7M as of Q2 2026.
- Federated Hermes sold 1,487 Medpace shares in Q2 2026, an estimated $686K.
- Medpace made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #574 holding.
- Federated Hermes first reported a position in Medpace in Q3 2016 and has held it in 39 quarters since.
- Federated Hermes's Medpace position peaked at $43.2M in Q4 2019.
- 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.